US: Pfizer "nearing" sale of infant-nutrition business
By Katy Askew | 18 April 2012
![]() |
Pfizer "nearing" baby food sale |
Pfizer is reportedly nearing an agreement to sell its infant nutrition business, with both Nestle and Danone linked to the deal.
The US pharmaceutical company has previously confirmed to just-food that it is "considering strategic options" for the business, including a "sale, spin-off or other transaction".
According to a report in the Wall Street Journal, Pfizer has stuck an agreement to sell the unit to Nestle for US$9bn. Meanwhile, other reports have suggested that Nestle and Danone have both submitted competing bids, valuing the business at around $10bn.
Pfizer is expected to announce a sale of the unit next week.
Sectors: Baby food, Mergers & acquisitions
Companies: Pfizer, Nestle, Danone
View next/previous articles
18 Apr 2012 -
Currently reading -
US: Pfizer "nearing" sale of infant-nutrition business
Related research
Nestle (Malaysia) Bhd (NESTLE) - Financial and Strategic SWOT Analysis Review
Nestle (Malaysia) Bhd (Nestle Malaysia) is a food and beverages company. The company, its undertakes manufacturing, marketing, and sale of instant noodles, chocolate confectionery products, cereals, culinary products, ice-cream, liquid milk, powdere...
Datamonitor's Nestle Purina PetCare Company - SWOT Analysis company profile is the essential source for top-level company data and information. Nestle Purina PetCare Company - SWOT Analysis examines the company’s key business structure and operations...
Nestle SA (NESN) - Financial and Strategic SWOT Analysis Review
Nestle SA (Nestle) is one of the world's leading nutrition, health and wellness companies. Being the holding company of the Nestle Group, it operates through its subsidiaries, associated companies and joint ventures across the world. The company has ...












There are currently no comments on this article
Be the first to comment on this article